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AbstrAct
The proprotein convertase enzyme FURIN processes immature pro-proteins 
into functional end- products. FURIN is upregulated in activated immune cells and it 
regulates T-cell dependent peripheral tolerance and the Th1/Th2 balance. FURIN also 
promotes the infectivity of pathogens by activating bacterial toxins and by processing 
viral proteins. Here, we evaluated the role of FURIN in LysM+ myeloid cells in vivo. 
Mice with a conditional deletion of FURIN in their myeloid cells (LysMCre-fur(fl/fl)) 
were healthy and showed unchanged proportions of neutrophils and macrophages. 
Instead, LysMCre-fur(fl/fl) mice had elevated serum IL-1β levels and reduced numbers 
of splenocytes. An LPS injection resulted in accelerated mortality, elevated serum pro-
inflammatory cytokines and upregulated numbers of pro-inflammatory macrophages. 
A genome-wide gene expression analysis revealed the overexpression of several 
pro-inflammatory genes in resting FURIN-deficient macrophages. Moreover, FURIN 
inhibited Nos2 and promoted the expression of Arg1, which implies that FURIN 
regulates the M1/M2-type macrophage balance. FURIN was required for the normal 
production of the bioactive TGF-β1 cytokine, but it inhibited the maturation of the 
inflammation-provoking TACE and Caspase-1 enzymes. In conclusion, FURIN has an 
anti-inflammatory function in LysM+ myeloid cells in vivo.
IntroductIon
The components of the innate immunity implement 
the recognition and elimination of microbes through a 
complex machinery involving factors that require a post-
translational proteolytic activation step to perform their 
effector functions. The functional maturation of dormant 
pro-proteins is catalyzed by the proprotein convertase 
subtilisin/kexin (PCSK) enzymes (PCSK1-2, FURIN, 
PCSK5-7, membrane-bound transcription factor site 1, 
PCSK9) [1]. The first seven PCSKs operate at a similar 
target site consisting of basic amino acids [K/R)-(X)
n-(K/R)↓, with n being 0, 2, 4 or 6 and X any amino 
acid], which results in a significant degree of functional 
redundancy in target recognition and processing in vitro. 
However, humans bearing mutations in the PCSK genes 
as well as PCSK-deficient experimental animal models 
have gene-specific phenotypes, which argues for substrate 
specificity in vivo [2].
FURIN was the first discovered and is thus the 
most studied conventional PCSK enzyme [3]. FURIN 
is ubiquitously expressed, and in cells it catalyzes 
the maturation of its targets in the secretory pathway, 
endosomes and on the cell surface. Due to its widespread 
expression, FURIN has a plethora of reported targets 
including cytokines, chemokines and growth factors as 
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well as other proteases like matrix metalloproteinases. In 
mice, the expression of Furin is essential for embryonic 
development, which has imposed limitations to our 
understanding of its cell-type specific function in vivo 
[3, 4]. However, the phenotypes of tissue-specific Furin 
deficient mice have demonstrated that FURIN cannot be 
compensated for by other PCSK enzymes in endothelial 
cells (Tie2Cre) or in T lymphocytes (CD4Cre) [5, 6].
FURIN’s regulatory role is also implicated in 
multiple human pathologies. For example, FURIN 
processes the beta-secretase enzyme in Alzheimer’s 
disease, SNPs in the Furin gene are associated with blood 
pressure levels, and elevated FURIN expression promotes 
metastatic activity in various cancer types, and the protein 
is found in advanced atherosclerotic plaques [7-10]. 
FURIN is an important modulator of the T-cell-dependent 
adaptive immunity; it becomes upregulated by T-cell-
receptor-mediated signaling and through the IL-12/STAT4 
pathway in T helper type 1 cells [11, 12]. A conditional 
deletion of FURIN in T cells results in the aberrant 
polarization of T helper cells, a lack of a protective 
cell-mediated host-defense as well as the spontaneous 
development of autoimmunity in aging animals due to 
a breakage in peripheral CD4+Foxp3+ T-regulatory-
cell-dependent immune tolerance [6, 13]. Consequently, 
targeting the activity of FURIN/PCSK has been reported 
to be beneficial for the experimental treatment of, for 
example, malignancies and rheumatoid arthritis [9, 14-16].
Previous reports have also implicated a role for 
PCSK enzymes in spleen [17]. FURIN is expressed in 
splenic red pulp, a zone enriched with macrophages, 
which regulate extramedullary myelopoiesis, the removal 
of senescent red cells, the cross-presentation of antigens 
as well as tolerance to self-antigens [18-20]. In addition, 
PCSK1 deficient mice show a marked disorganization 
of the marginal zone and red pulp [21]. In addition to 
the cellular pro-proteins also the components of several 
infectious agents, including the envelopes of the HI and 
Influenza viruses as well as the toxins of Bacillus antracii 
and Pseudomonas aeruginosa require a PCSK-dependent 
proteolysis step to exert their pathogenic function [22-24]. 
Therefore, inhibitors can protect the host from invading 
PCSK-dependent pathogens and serve as adjuvants to 
antibiotics [25]. As the innate immune system forms 
the first line of defense, targeting PCSKs specifically in 
myeloid cells could be a potent and well-tolerated strategy 
to block infections. However, the consequences of PCSK 
inhibition specifically in the cells of the innate immune 
system in vivo have remained ambiguous. To address this 
conundrum we have here characterized a novel tissue-
specific knock-out mouse model, in which FURIN is 
deleted in Lysozyme M positive cells, i.e. chiefly in 
activated macrophages and granulocytes (LysMCre-fur(fl/
fl)) [26].
results And dIscussIon
lysMcre-fur(fl/fl) mice have a reduced number 
of splenocytes and elevated levels of the pro-
inflammatory IL-1β cytokine in their serum
Previous studies using germ-line deletions and 
siRNA have demonstrated that PCSK1 and PCSK7 
modulate the secretion process of innate cytokines [21] 
and rescue unstable MHCI molecules on dendritic cells, 
respectively [27]. Others and we have further shown 
that FURIN is upregulated in the LPS activated CD14+ 
cells [10], and in the plasma of chronic typhoid carriers 
[28]. To directly address whether FURIN expression in 
myeloid cells regulates immunity in vivo, we generated 
a mouse model with a conditional deletion of FURIN 
in LysM+ cells. LysMCre-fur(fl/fl) mice were born under 
normal Mendelian ratios, and unlike T-cell specific 
CD4Cre-fur(fl/fl) mice [6], they did not show age-related 
health problems such as inflammatory bowel disease 
(supplementary Figure S1A, B). Notably, in contrast 
to the reportedly large spleens of PCSK1 KO mice 
[21] LysMCre-fur(fl/fl) animals had significantly reduced 
numbers of splenocytes compared to controls, which could 
indicate that FURIN regulates hematopoiesis in LysM+ 
cells, or cellular homeostasis in the spleen (Figure 1A, 
supplementary Figure S1C, D). The mechanism(s) leading 
to the reduction in splenocyte numbers in LysMCre-fur(fl/
fl) animals remains unclear, but the lowered FURIN levels 
in the bone marrow (ca. 60% less mRNA expression, 
supplementary Figure S2A) could disrupt the delicate 
microenvironment by reducing the proteolytic maturation 
of hematopoietic growth factors or extracellular matrix 
receptors [29].
As expected, FURIN was almost completely 
(>95% less mRNA) absent from both the neutrophils and 
macrophages of LysMCre-fur(fl/fl) mice (supplementary 
Figure S2B, C). A flow cytometric analysis demonstrated 
that the lack of FURIN did not significantly alter the 
proportions of macrophages (F4/80+CD11b+) and 
neutrophils (Gr1+CD11b+) in the peritoneal cavity 
(Figure 1B), spleen (supplementary Figure S3A) or bone 
marrow (supplementary Figure S4A). We next analyzed 
whether deleting FURIN in myeloid cells imposed 
secondary effects on lymphoid cells, and found that the 
gross numbers of splenic CD3+ T and B220+ B cells were 
unaffected (supplementary Figure S3B). Instead, there 
was a small, but significant reduction in the numbers 
of CD3+CD4+CD8- T helper cells in the spleen while 
the proportion of CD3+CD4-CD8+ cytotoxic T cells was 
elevated (supplementary Figure S3C). The lower ratio of 
splenic CD4+/CD8+ T cells has previously been associated 
with inflammation [30], but the quantification of CD62L+ 
T cells did not reveal marked differences in the numbers 
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of memory T cells between LysMCre-fur(fl/fl) and littermate 
control animals (supplementary Figure S3C). Collectively, 
the analyses of different cell compartments indicate that 
FURIN expression in LysM+ cells is not essential for 
the development of neutrophils or macrophages, but it 
promotes the development of splenocytes and may also 
indirectly affect the CD4+/CD8+ T cell ratio in the spleen. 
We have previously demonstrated that deleting 
FURIN in T cells results in the upregulation of both the 
Th1 and Th2 signature cytokines in serum [6]. To address 
how FURIN expression in LysM+ cells controls the 
production of innate cytokines in steady state we measured 
the levels of pro-inflammatory IL-1β, TNF-α, IL-6 and 
MCP-1 cytokines as well as the anti-inflammatory IL-10 in 
serum (Figure 1C). These data demonstrated that FURIN 
expression in myeloid cells attenuates the production of 
pro-inflammatory IL-1β, which is indicative of an auto-
inflammatory phenotype [31, 32].
Genome-wide rnA microarray analysis reveals 
the upregulation of several pro-inflammatory 
genes in FURIN deficient macrophages
Although proprotein convertases process their 
target molecules post-translationally, deleting PCSKs 
also results in aberrant gene expression signatures, which 
gives clues about the mechanism of the actions of PCSKs 
in a given cell type [6, 12, 33]. To address how FURIN 
regulates the genetic signature in macrophages we profiled 
their gene expression using qRT-PCR and microarray 
analyses. Similarly to human CD14+ monocytes [10] 
FURIN was efficiently upregulated in mouse peritoneal 
macrophages that were activated with LPS+/- IFNγ in 
vitro, (supplementary Figure S2B). The lack of FURIN 
in endothelial cells (Tie2Cre) causes the compensatory 
expression of other biochemically redundant PCSKs 
[5], which interferes with the interpretation of FURIN’s 
biological significance. However, we observed that 
deleting FURIN in macrophages did not affect the 
expression of other PCSK enzymes (supplementary Figure 
S2D). These data indicate that the LysMCre-mediated 
deletion can be reliably used to assess the specific role of 
FURIN in LysM+ cells.
In order to characterize the FURIN-dependent 
global gene expression patterns we performed a genome-
wide microarray analysis using resting peritoneal 
macrophages from LysMCre-fur(fl/fl) and littermate WT 
animals (Figure 2A, 2B). FURIN deficient peritoneal 
macrophages displayed a reproducible upregulation of 
many genes expressed in activated macrophages, such 
Figure 1: Proportions of splenocytes, peritoneal macrophages, neutrophils and serum cytokines in steady state 
lysMcre-fur(fl/fl) mice. A. Total numbers of live splenocytes from LysMCre-fur(fl/fl) (KO) and WT littermate control mice were 
calculated using trypan blue staining (n = 7/genotype, 6-8 weeks of age). b. Flow cytometric analyses of F4/80+CD11b+ (macrophages) 
and Gr1+CD11b+ (neutrophils) peritoneal cells were performed from LysMCre-fur(fl/fl) and WT littermate control mice (n = 4/genotype, 6-8 
weeks of age). c. Levels of serum cytokines from steady state LysMCre-fur(fl/fl) and WT littermate control mice (n = 6/genotype, 6-8 weeks 
old mice). Plots represent average ± SEM. Statistics were calculated with the two-tailed unpaired Student’s t-test.
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as Serpinb1a, Serpinb2, Hcar2 , Egr1, Il6, Il1β, Ptgs2, 
Ccl2, Ccl7 and C5ar1 [34-38]. In addition, we observed 
an enhanced expression of Dusp6 and Fcgr1, which are 
downregulated in alternatively activated macrophages 
[39]. In contrast, among the downregulated genes of 
FURIN deficient macrophages, we detected for example 
Atf7 whose deletion is associated with the constitutive 
activation of macrophages [40]. FURIN is induced by its 
substrate TGF-β1 [41]. Accordingly, the expression of 
Ccnd1 was enhanced in the absence of FURIN, similarly 
to what was seen in TGF-β1 null cells [42]. These data 
suggest that FURIN has an intrinsic inhibitory function on 
the expression of genes that associate with the activation 
of pro-inflammatory M1 type macrophages [43].
lysMcre-fur(fl/fl) mice show increased lethality, 
upregulated pro-inflammatory cytokines and 
elevated numbers of ly6-c+ macrophages after 
an LPS injection
Both the high IL-1β levels in serum and the 
results from the microarray analysis pointed to a pro-
inflammatory phenotype in LysMCre-fur(fl/fl) mice. To 
test if FURIN in LysM+ cells also restrains inflammatory 
responses in vivo we subjected mice to lipopolysaccharide 
(LPS) triggered inflammation. LysMCre-fur(fl/fl) and 
littermate WT mice were first challenged with a single 
i.p. injection of 25 mg/kg (LPS) and monitored for 72 
hours (Figure 3A). We observed a significantly higher 
mortality in LysMCre-fur(fl/fl) mice 24 hours post-injection 
(62% mortality in KO vs. 38% mortality in WT) (p = 
Figure 2: Genome-wide gene expression analyses in resting wild type and FURIN deficient peritoneal macrophages. 
A. The 19 most differentially (log fold change > |1| and multiple testing corrected p-value < 0.05) expressed genes between wild type and 
FURIN deficient unstimulated peritoneal macrophages. For visualization purposes, the mean of each gene’s expression has been subtracted 
from individual expression values to highlight the differences between the samples. The red and green colors indicate an induction or 
suppression of gene expression, respectively, relative to the mean across samples. The figure shows two biological replicates for both 
genotypes. b. A scatter plot of the mean gene expression across replicates of wild type and FURIN deficient unstimulated peritoneal 
macrophages. Selected genes with a log fold change > |1| have been highlighted. The orange lines show the limit where the log fold change 
equals 1 or -1. 
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0.0109), which indicates an increased sensitivity to a pro-
inflammatory stimulus. 
A lower dose of LPS (100 µg/kg) was then used 
to evaluate how the myeloid-cell-expressed FURIN 
regulates cytokine levels in the serum and the generation/
migration of pro-inflammatory F4/80+CD11b+Ly6C+Ly6G- 
monocytes/macrophages, which are characterized by 
accelerated inflammatory effector functions including 
the high production of IL-6, IL-1β, TNF-α, NOS2 and 
CCL2 [44, 45]. LPS-injected LysMCre-fur(fl/fl) mice had 
significantly enhanced levels of the pro-inflammatory 
cytokines TNF-α and IL-6 1 and 3 hours post-infection, 
respectively, whereas the production of anti-inflammatory 
IL-10 was reduced at the 3-hour time-point (Figure 3B-
3D). 
In addition, at 3 hours post-injection there 
was a significant augmentation in the proportion of 
F4/80+CD11b+Ly6C+Ly6G- M1 type macrophages in 
the spleen (Figure 3E). A qRT-PCR analysis on ex vivo 
activated FURIN KO macrophages further showed an 
upregulation in the expression of Nos2 (M1 marker gene) 
upon an LPS/IFN-γ stimulus, whereas the IL-4 induced 
expression of Arg1 (M2 marker gene) was clearly reduced 
[43] (Figure 3F). Previously, the prominence of the M1 
over the M2 macrophage phenotype has been associated 
with an increased susceptibility to a septic shock [46, 47], 
as was observed in LPS-challenged LysMCre-fur(fl/fl) mice.
PCSKs control the quantity and activation of the 
human Toll-like receptor 7 (TLR7) host responses by 
direct proteolysis [48]. We next tested if the expression 
levels of LPS/TLR4-dependent genes are affected by the 
FURIN deficiency in peritoneal macrophages. First, the 
time course changes in the mRNA expression of the Il1b, 
Tnfa, Il6 and Il10 genes indicated an upregulated base 
line expression but roughly similar dynamics in response 
to LPS in FURIN deficient macrophages compared to 
Figure 3: LPS-challenged LysMCre-fur(fl/fl) mice exhibit higher mortality, accelerated inflammation and an upregulated 
pro-inflammatory macrophage response. A. Kaplan Meier survival curve for LysMCre-fur(fl/fl) and WT littermate control mice (n 
= 8/genotype, 6-8 weeks of age, all male) after the intraperitoneal injection of a single lethal dose of LPS (25 mg/kg). LysMCre-fur(fl/fl) 
mice exhibited a significantly higher mortality than WT littermate controls during the first 24 h. b.-d. Level of serum cytokines TNF-α, 
IL-6, IL-10 in LysMCre-fur(fl/fl) and WT littermate controls mice (n = 4/genotype, 6-8 weeks of age) after an intraperitoneal injection with 
NaCl (0.9%) or 100 µg/kg of LPS (plots represent average ± SEM). Statistics were calculated with the two-tailed unpaired Student’s t-test. 
e. Flow cytometric analysis of a splenic F4/80+CD11b+Ly6C+Ly6G- cell population in LysMCre-fur(fl/fl) mice and WT littermate control 
mice (n = 3/genotype, 6-8 weeks of age) injected with NaCl (0.9%) or LPS (100 µg/kg) at 0, 1h and 3h. The arrows indicate the gating 
strategy. (Plots represent average ± SEM). Statistics were calculated using the two-tailed unpaired Student’s t-test. F. Nos2 and Arg1 mRNA 
expression was assessed by quantitative RT-PCR in wild type and FURIN deficient peritoneal macrophages treated with LPS+IFN-γ (1 µg/
ml+20 ng/ml) or IL-4 (50 ng/ml). One representative experiment out of three independent experiments is shown.
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controls (Figure 4A). Likewise, a focused analysis of 
TLR-associated mRNAs using microarray data showed 
only minimal differences between the dynamic expression 
patterns of WT and FURIN KO macrophages (Figure 4B). 
However, the dynamic expression of several other pro-
inflammatory genes, including Trem1, Nos2, Il15, Il33, 
and Il12rb1, was inhibited by FURIN in LPS activated 
macrophages (Figure 4C) [49-52]. These findings were 
accompanied by the repression of the genes Ch25h, Olr1 
and Arg1, which are typically induced in alternatively 
activated macrophages [38]. Finally, we evaluated the 
expression of pro- and anti-inflammatory cytokines in 
peritoneal macrophages that were stimulated with various 
TLR ligands and IFN-γ (supplementary Figure S5). These 
results show that the anti-inflammatory function of FURIN 
cannot be attributed to a specific stimulus, but can be seen 
in TLR2, TLR4 and TLR7/8 activated macrophages. 
Collectively, these data suggest that FURIN is dispensable 
for the immediate TLR4 responses, but underscore the 
importance of FURIN as an anti-inflammatory factor in 
both resting and activated macrophages.
FURIN deficient macrophages secrete less 
bioactive TGFβ-1 cytokine but show elevated 
expression levels of the activated TNF-α 
Converting Enzyme (TACE) and Caspase-1 p20
The production of several cytokines secreted by 
macrophages, including TNF-α, IL-1β and TGF-β1, is 
dependent on proteolytic processing in the cell [53]. 
Specifically, TGF-β1 is initially produced as an inactive 
Figure 4: LPS-induced gene expression dynamics in wild type and FURIN deficient peritoneal macrophages. A. mRNA 
expression levels were determined using quantitative RT-PCR, and the normalized expression in the unstimulated WT sample was arbitrarily 
set to 1. Curves show changes in the expression of Il1b, Tnfa, Il6 and Il10 mRNAs in WT and FURIN KO peritoneal macrophages that 
were left unstimulated or were stimulated with LPS (1µg/ml) for 1-24h as indicated. The housekeeping gene 18S was used to normalize 
the gene expression. (The figure shows one representative experiment of two independent experiments ± SEM). b. Microarray analysis of 
the TLR signaling pathway genes. Log2 fold changes for all genes in both WT and FURIN KO peritoneal macrophages were computed 
for each time point with an LPS (1µg/ml) stimulation, respective to the unstimulated condition. At each time point, the ratio of the fold 
changes illustrates the degree of difference in the LPS response over time. The figure shows the average of two independent experiments. 
The red color indicates an increase and the green a decrease in the log2 fold change difference. c. Genome wide analysis of the genes with 
the strongest differential response to a LPS stimulation between WT and FURIN KO peritoneal macrophages. A selection of differentially 
responding genes showing greatest differences between ratios at one or several time points are presented. Data were processed as in B.
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pro-cytokine, which is converted into an active factor via 
a complex post-translational cascade involving a cleavage 
step catalyzed by FURIN [6, 54]. Further, undermined 
TGF-β1 signaling has been associated with an impaired 
transit between the macrophage (M1/M2) phenotypes, 
sustained inflammation and delayed wound healing [55]. 
Also, TNF-α Converting Enzyme (TACE), which releases 
soluble TNF-α from its membrane-bound precursor, is 
proteolytically activated by a FURIN-like proprotein 
convertase [56] whose deletion results in the development 
of an anti-inflammatory phenotype in macrophages [57]. 
In addition, the activation/deactivation of the Caspase-1 
cascade, which directly processes IL-1β, plays an 
important role in the dynamics of macrophage polarization 
[58]. Previous data also imply a functional connection 
between PCSK activity and IL-1β; the proteolytic cleavage 
of the anthrax toxin by FURIN activates Caspase-1 in 
macrophages [59] and high levels of IL-1β have been 
observed in an experimental model of arthritis in mice that 
were treated with a FURIN inhibitor [60].
In order to find out if FURIN regulates the 
proteolytic maturation of the aforementioned inflammatory 
cytokines in macrophages we analyzed the secretion of 
bioactive TGF-β1 as well as the proteolytic activation of 
TACE and Caspase-1. First, FURIN KO macrophages 
were found to secrete significantly lower levels of 
bioactive TGF-β1 in ELISA analyses than cells from wild-
type controls, whereas the Tgfb1 mRNA levels were not 
affected (Figure 5A, supplementary Figure S6). In contrast, 
we found that the lack of FURIN upregulated the mature 
TACE protein in LPS-stimulated peritoneal macrophages 
(Figure 5B), which is in line with the elevated TNF-α 
production in LPS-challenged LysMCre-fur(fl/fl) mice in 
vivo (Figure 3B). These data also indicate that FURIN is 
not the bona-fide PCSK that activates TACE, and suggest 
that another macrophage-expressed and LPS-induced 
PCSK enzyme, such as PCSK6 or PCSK7 (supplementary 
Figure S2D), could be more important for the maturation 
of TACE in vivo [61]. Finally, an analysis of Caspase-1 
processing also showed a higher production of Caspase-
1p20 in FURIN deficient macrophages (Figure 5C). 
These data are consistent with the observed higher levels 
of serum IL-1β and reveal a novel proteolytic regulator 
(FURIN) for this key pro-inflammatory cytokine.
The analyses of proteolytically activated 
macrophage cytokines thus showed that a FURIN 
deficiency reduces the production of anti-inflammatory 
TGF-β1 but upregulates the activation of the TACE 
Figure 5: FURIN deficient macrophages produce less bioactive TGF-β1 and show hyperactivation of TACE and 
Caspase-1 p20. A. The production of bioactive TGF-β1 was measured in the supernatants of unstimulated wild type and FURIN deficient 
peritoneal macrophages using an enzyme linked immunosorbent assay (ELISA) (n = 3/genotype). Plots represent average ± SEM. Statistics 
were calculated with the two-tailed unpaired Student’s t-test. b. WT and FURIN deficient peritoneal macrophages were left unstimulated or 
were stimulated with LPS (1 µg/ml) for 5-30 minutes as indicated. Mature Tumor Necrosis Factor-α-Converting Enzyme (TACE) (93 kDa) 
and β-Actin (43 kDa) were detected by western blotting. Normalized (TACE/Actin) levels are presented in the upper panel. Shown is one 
representative experiment out of three replicates with similar results. c. FURIN deficient or littermate wild type bone marrow macrophages 
(n = 2/genotype) were left unstimulated or were stimulated with ultrapure LPS (500 ng/ml) for 2 hours, then ATP (1mM) was added to the 
cells for 15 min. Pro-Caspase (55 kDa), Caspase-1 p20 (20 kDa) and actin (43 kDa) were detected with western blotting.
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and Caspase-1 enzymes. These findings together with 
the inherent upregulation of pro-inflammatory mRNAs 
collectively contribute to the pro-inflammatory phenotype 
of LysMCre-fur(fl/fl) mice. Understanding the underlying 
mechanism(s) of aberrant cytokine expressions by 
FURIN deficient macrophages clearly requires further 
studies, but at least reduced TGFβ-1 maturation is likely 
to play a role [62]. In conclusion, our data indicate that 
inhibiting FURIN specifically in innate immune cells 
could strengthen host responses. This, together with the 
plausible reduction in the activation of pathogens, could 
be beneficial for treating and preventing PCSK-dependent 
infections.
MAterIAls And Methods
Experimental animals
Mice bearing floxed fur alleles [4] were backcrossed 
six times with C57BL/6 mice. LysMCre mice with the 
C57BL/6 background were purchased from Taconic. 
LysMCre mice were bred with fur(fl/fl) animals to generate 
myeloid-specific FURIN knockout mice LysMCre-
fur(fl/fl). Mice were housed under pathogen-free standard 
conditions. All mouse experiments were performed in 
accordance with the National Animal Experiment Board, 
Finland, (Permit# ESAVI/2837/04.10.07/2015).
Isolation, culture and ex vivo activation of 
macrophages from the mouse peritoneal cavity 
and of neutrophils from the bone marrow
Peritoneal cells were extracted from the peritoneal 
cavity and cultured following a previously published 
protocol [63]. After 1 h incubation WT and FURIN 
deficient peritoneal macrophages were stimulated with 
LPS (1 µg/ml, E. coli 0127:B8 serotype; Sigma-Aldrich, 
St Louis, MO, USA), TLR ligands (Zymosan: 10 µg/ml, 
R848: 1 µg/ml; both from InvivoGen, San Diego, CA, 
USA) and/or cytokines (IFN-γ: 20 ng/ml, IL-4: 50 ng/ml; 
PeproTech, Rocky Hill, NJ, USA). After stimulation, the 
cells were scraped to dislodge them and collected for RNA 
extraction (RNAeasy, Qiagen, Düsseldorf, Germany). 
Neutrophils were isolated from the bone marrow of 
LysMCre-fur(fl/fl) and wild-type mice with the Anti-Ly-6G 
MicroBead Kit (Miltenyi Biotec Norden AB, Lund, SE) 
and were left unstimulated or were stimulated with 100 
µM of fMLP for 1 hour at 37 °C. 
Flow cytometric analyses
Peritoneal, splenic and bone marrow cells were 
analyzed using flow cytometry (BD FACSCanto™ II) 
and the FlowJo software (Treestar Inc, Ashland, OR, 
USA). Anti-CD16/CD32 (Clone: 93) (eBioscience, 
San Diego, CA, USA) was used to block Fc receptors 
and cell populations were surface stained following the 
eBioscience FACS protocol with PerCP-Cy5.5- labeled 
anti- F4/80 (BM8), PE-labeled anti-Gr-1 (RB6-8C5), PE-
Cy7-labeled anti-CD11b (M1/70), FITC-labeled anti-B220 
(RA3-6B2), APC-labeled anti-CD3, PE-Cy7 labeled anti-
CD4 (RM4-5), APC-H7 labeled anti-CD8 (53-6.7), PE-
labeled anti-CD62L (MEL-14), PE-labeled anti-Ly-6G 
(RB6-8C5), APC labeled anti-Ly-6C (HK1.4), PE-Cy7-
labeled anti-CD11c (N418), FITC-labeled anti-CD11b 
(M1/70) (eBioscience, San Diego, CA, USA). 
Cytokine measurements
Serum cytokines were measured in both steady 
state and LPS injected mice. Briefly, LysMCre-fur(fl/fl) 
and WT littermate mice (6-8 weeks of age) were injected 
intraperitoneally with NaCl (0.9%) or LPS (100 µg/kg, 
E. coli 111:B4 serotype; Sigma-Aldrich) and serum was 
collected at the 0, 1, 3 h time points. The serum cytokines 
TNF-α, IL-6, MCP-1 and IL-10 were quantified using 
the BD™ Cytometry Bead Array Mouse Inflammation 
Kit (Catalog # 552364) according to the manufacturer’s 
instructions (BD Biosciences, Franklin Lakes, NJ, USA). 
IL-1β levels were measured with mouse IL-1 beta ELISA 
Ready-SET-Go!® (eBioscience, San Diego, CA, USA) 
(Catalog # 88-7013-22). Bioactive TGF-β1 was measured 
in the supernatants of cultured peritoneal macrophages 
isolated from LysMCre-fur(fl/fl) and WT littermate mice 
using Human/Mouse TGF beta 1 ELISA Ready-SET-Go! 
(2nd Generation) (Catalog # 88-8350-76) (eBioscience, 
San Diego, CA, USA). 
LPS induced endotoxemia
LysMCre-fur(fl/fl) and WT littermate mice (6-8 weeks 
of age) were injected intraperitoneally with a lethal dose of 
LPS (25 mg/kg, E. coli 0111:B4 serotype; Sigma Aldrich, 
St Louis, MO, USA) or with NaCl (0.9%) as a control. 
Survival of the mice was monitored for 72 h at 3-hour 
intervals.
Quantitative real-time polymerase chain analyses
The mRNA expression in stimulated and non-
stimulated peritoneal macrophages was assessed using 
qRT-PCR. Briefly, total RNA was extracted using the 
RNeasy kit (Qiagen, Düsseldorf, Germany), quantified 
using a NanoDrop ND-2000 (Thermo Fisher Scientific, 
Massachusetts, USA) and transcribed into cDNA with the 
iScript Select cDNA Synthesis Kit (Bio-Rad, Hercules, 
CA, USA). Gene expression levels were examined using 
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the Bio-Rad CFX96 Real-Time System and the Sso Fast 
Eva Green Supermix (Bio-Rad, Hercules, CA, USA). The 
primers used for quantitative real-time PCR are shown 
in the supplementary Table S1. Gene expression was 
normalized to 18s levels; the normalized threshold cycle 
(Ct) values were subtracted from the target Ct values of 
each sample (deltaCt). The relative levels of the target 
mRNA were calculated as 2-deltadeltaCt. 
Microarray data analysis
Two biological replicates of FURIN KO and 
WT peritoneal macrophages were left unstimulated or 
were stimulated for 1, 4 and 24 hours with LPS (1 µg/
ml)(E. coli 0127:B8 serotype; Sigma Aldrich, St Louis, 
MO, USA). The samples were collected and the RNA 
was isolated using Qiagen RNeasy on-column DNase 
(Qiagen, Düsseldorf, Germany). 50 ng of purified RNA 
was amplified and dye labeled using Agilent’s Low Input 
Quick Amp Labeling kit and RNA Spike In kit (Agilent 
Technologies, California, USA). Initial and purified RNA 
contents along with dyed and amplified cRNA contents 
were measured with a NanoDrop ND-2000 (Thermo Fisher 
Scientific, Massachusetts, USA). RNA and cRNA quality 
was inspected using the Agilent 2100 Bioanalyzer RNA 
6000 Nano kit (Agilent Technologies, California, USA). 
300ng of Cy-3 and 300ng of Cy-5 labeled sample were 
hybridized together on an Agilent Mouse Chip 8x60K 
(Design ID 028005) (Agilent Technologies, California, 
USA) overnight at 65°C using the Gene Expression 
Hybridization kit. The chips were washed with the Gene 
Expression Wash Pack according to the instructions. The 
chips were scanned using an Agilent Technologies Scanner 
model G2565CA using the scan profile AgilentG3_
GX_2Color. Scan results were converted into numerical 
data by the Agilent Feature Extraction software version 
10.7.3. The data was analyzed using the R software 
[64]. Raw probe level intensity values were normalized 
with loess regression and quantile normalization using 
R package “limma” to robustly generate sample-wise 
comparability [65].
Differential gene expression was evaluated 
using the log2-transformed fold change difference and 
statistical testing using the two-sample Student’s t-test. 
Genes showing an average expression lower than the 
log2 transformed intensity value 6 were filtered out as 
non-informative. The Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathway database was used to obtain 
a gene set involved in Toll-like receptor signaling. [66]. 
The raw microarray data are available at Gene Expression 
Omnibus (GEO): http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token=ililkmqqvvqlryn&acc=GSE84117.
Western blot analyses
For the Caspase-1 experiment bone marrow 
macrophages were cultured using a standard protocol 
[63] and were left unstimulated or were stimulated for 
6 hours with ultrapure LPS (E. coli 0111:B4, 500 ng/
ml; InvivoGen, San Diego, CA, USA). Cells were 
washed twice with PBS and incubated with ATP 
(1mM, Sigma Aldrich, St Louis, MO, USA). Next, the 
cells were collected and lysed in a buffer specific for 
Caspase-1 (50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM 
Ethylenediaminetetraacetic acid (EDTA) pH: 8.2 mM 
Ethyleneglycoltetraacetic acid (EGTA) pH: 7.5, 10% 
Glycerol, 1% Triton X-100, 50 mM Sodium fluoride, 200 
μM Sodium vanadate) [67]. For the TACE-1 experiment, 
peritoneal macrophages were left unstimulated or were 
stimulated with LPS for 5-30 minutes (1 µg/ml, E. coli 
0127:B8 serotype; Sigma Aldrich, St Louis, MO, USA). 
Next, the cells were collected and lysed in a buffer specific 
for TACE (1% Triton X-100, 15 mM NaCl, 50 mM Tris 
HCL pH 7.4, protease inhibitors cocktail (Roche), 10mM 
1,10-phenanthroline) [68]. Equal amounts of proteins were 
separated on 12% polyacrylamide gels and transferred 
onto nitrocellulose membranes (Whatman, GE Healthcare, 
Pollards Wood, UK). The proteins were probed with a 
primary antibody, either anti-ADAM17-cytoplasmic 
domain (ab39162; abcam) or anti-caspase-1-t/ICE 
(AHZ0082; Invitrogen), followed by a HRP-conjugated 
secondary antibody (RnD systems, Minneapolis, MN, 
USA). Anti-actin (MAB1501R; Merck Millipore, 
Billerica, MA, USA) was used as a loading control. 
Immunoblots were visualized with an ECL detection 
system (GE Healthcare, Pollards Woods, UK). Signal 
intensities were analyzed using the NIH ImageJ software. 
statistical analysis
Statistical analyses were performed using the 
two-tailed unpaired Student’s t-test. P ˂ 0.05 indicates 
statistical significance and the variability is depicted using 
the standard error of the mean (SEM). The Kaplan Meier 
test was applied to estimate survival in the LPS induced 
endotoxemia experiment.
conventions and Abbreviations
PCSK: Proprotein Convertase Subtilisin/Kexin 
type; FBS: Fetal Bovine Serum; ELISA: Enzyme-Linked 
Immunosorbent Assay; CBA: Cytometric Bead Array; 
qRT-PCR: quantitative Reverse Transcription Polymerase 
Chain Reaction; IL: Interleukin; TLR: Toll Like Receptor; 
LPS: Lipopolysaccharide; R848: Resiquimod; IFN-γ: 
Interferon gamma; TNF-α: Tumor Necrosis Factor 
alpha; MCP-1: Monocyte Chemotactic Protein 1; TACE: 
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Tumor Necrosis Factor Alpha Converting Enzyme; 
ADAM17: ADAM Metallopeptidase Domain 17; Ptgs2: 
Cyclooxygenase-2; CXCL: C-X-C motif Chemokine; 
CCL: Chemokine (C-C motif) Ligand; Serpinb1a: 
Serine (or cysteine) peptidase inhibitor, clade B, 
member 1a; Serpinb2: Serpin Peptidase Inhibitor, Clade 
B (Ovalbumin), Member 2 ; Hcar2: Niacin Receptor 1 
; Egr1: Early Growth Response 1; C5ar: Complement 
Component 5a Receptor 1; Dusp6: Dual specificity 
phosphatase 6; Fcgr1: Fc Fragment of IgG, High Affinity 
Ia, Receptor; Atf7: Activating Transcription Factor 7; 
Ccnd1: Cyclophilin C; CD11b: Cluster of Differentiation 
molecule 11b, Integrin alpha M; Ly6C: Lymphocyte 
antigen 6C; Ly6G: Lymphocyte antigen 6G; Trem1: 
Triggering receptor expressed on myeloid cells 1; Il12rb1: 
Interleukin 12 Receptor, Beta 1; Ch25h: Cholesterol 
25-Hydroxylase; Olr1: Oxidized Low Density Lipoprotein 
(Lectin-Like) Receptor 1 ; Nos2: inducible Nitric Oxide 
Synthase 2; Arg1: Arginase 1.
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